IL18 and neoplasm: These cells (CAR-T/IL-18) induced a general change in the profile of immune cells associated with the tumor, increasing the number of CD206-M1 macrophages and NKG2D+ NK cells, and decreasing Tregs, suppressive CD103+ DCs, and M2 macrophages, besides prevented exhaustion of CAR T cells in the long term.